$377.78
22.786.42%
Last update: Nov 4, 4:42 PM
BeOne Medicines Ltd
ONCNASDAQ
The average analyst price target for BeOne Medicines is $387.40, 1.2% above the current price. Of 16 analysts, 16 rate it Buy. Targets range from $311 to $459. The latest change came on Oct 8, 2026, when RBC Capital raised its price target on BeOne Medicines from $450 to $459 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
